Picture of Madrigal Pharmaceuticals logo

MDGL — Madrigal Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapMomentum Trap

Brief: CSPC Pharmaceutical Enters Into Exclusive License Agreement For SYH2086 With Madrigal

July 30 (Reuters) - CSPC Pharmaceutical Group Ltd 1093.HK:

ENTERING INTO EXCLUSIVE LICENSE AGREEMENT FOR SYH2086 WITH MADRIGAL

ELIGIBLE FOR UP TO $2.075 BILLION IN PAYMENTS

DEAL FOR  GLOBAL DEVELOPMENT, MANUFACTURING AND COMMERCIALIZATION OF SYH2086

Further company coverage: 1093.HK

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Madrigal Pharmaceuticals

See all news